These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 24794439)
1. Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Kinsey C; Balakrishnan V; O'Dell MR; Huang JL; Newman L; Whitney-Miller CL; Hezel AF; Land H Cell Rep; 2014 May; 7(4):1143-55. PubMed ID: 24794439 [TBL] [Abstract][Full Text] [Related]
2. PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways. Kaistha BP; Lorenz H; Schmidt H; Sipos B; Pawlak M; Gierke B; Kreider R; Lankat-Buttgereit B; Sauer M; Fiedler L; Krattenmacher A; Geisel B; Kraus JM; Frese KK; Kelkenberg S; Giese NA; Kestler HA; Gress TM; Buchholz M Cancer Res; 2016 Jan; 76(1):96-107. PubMed ID: 26669866 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401 [TBL] [Abstract][Full Text] [Related]
4. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
5. p53 status determines the role of autophagy in pancreatic tumour development. Rosenfeldt MT; O'Prey J; Morton JP; Nixon C; MacKay G; Mrowinska A; Au A; Rai TS; Zheng L; Ridgway R; Adams PD; Anderson KI; Gottlieb E; Sansom OJ; Ryan KM Nature; 2013 Dec; 504(7479):296-300. PubMed ID: 24305049 [TBL] [Abstract][Full Text] [Related]
6. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. von Figura G; Fukuda A; Roy N; Liku ME; Morris Iv JP; Kim GE; Russ HA; Firpo MA; Mulvihill SJ; Dawson DW; Ferrer J; Mueller WF; Busch A; Hertel KJ; Hebrok M Nat Cell Biol; 2014 Mar; 16(3):255-67. PubMed ID: 24561622 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123 [TBL] [Abstract][Full Text] [Related]
8. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice. Görgülü K; Diakopoulos KN; Ai J; Schoeps B; Kabacaoglu D; Karpathaki AF; Ciecielski KJ; Kaya-Aksoy E; Ruess DA; Berninger A; Kowalska M; Stevanovic M; Wörmann SM; Wartmann T; Zhao Y; Halangk W; Voronina S; Tepikin A; Schlitter AM; Steiger K; Artati A; Adamski J; Aichler M; Walch A; Jastroch M; Hartleben G; Mantzoros CS; Weichert W; Schmid RM; Herzig S; Krüger A; Sainz B; Lesina M; Algül H Gastroenterology; 2019 Jan; 156(1):203-217.e20. PubMed ID: 30296435 [TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332 [TBL] [Abstract][Full Text] [Related]
10. N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer. Su Y; Li J; Witkiewicz AK; Brennan D; Neill T; Talarico J; Radice GL Oncogene; 2012 Oct; 31(41):4484-9. PubMed ID: 22158044 [TBL] [Abstract][Full Text] [Related]
11. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173 [TBL] [Abstract][Full Text] [Related]
12. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras. Sung S; Choi J; Cheong H Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954 [TBL] [Abstract][Full Text] [Related]
14. Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Qiu W; Sahin F; Iacobuzio-Donahue CA; Garcia-Carracedo D; Wang WM; Kuo CY; Chen D; Arking DE; Lowy AM; Hruban RH; Remotti HE; Su GH Oncotarget; 2011 Nov; 2(11):862-73. PubMed ID: 22113502 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215 [TBL] [Abstract][Full Text] [Related]
16. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173 [TBL] [Abstract][Full Text] [Related]
17. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
18. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Pérez-Mancera PA; Rust AG; van der Weyden L; Kristiansen G; Li A; Sarver AL; Silverstein KA; Grützmann R; Aust D; Rümmele P; Knösel T; Herd C; Stemple DL; Kettleborough R; Brosnan JA; Li A; Morgan R; Knight S; Yu J; Stegeman S; Collier LS; ten Hoeve JJ; de Ridder J; Klein AP; Goggins M; Hruban RH; Chang DK; Biankin AV; Grimmond SM; ; Wessels LF; Wood SA; Iacobuzio-Donahue CA; Pilarsky C; Largaespada DA; Adams DJ; Tuveson DA Nature; 2012 Apr; 486(7402):266-70. PubMed ID: 22699621 [TBL] [Abstract][Full Text] [Related]
19. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669 [TBL] [Abstract][Full Text] [Related]
20. Of autophagy and in vivo pancreatic carcinogenesis: the p53 status matters! Jonckheere N; Vincent A; Van Seuningen I Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):423-5. PubMed ID: 24939064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]